Showing results (111-120 of 162) with videos related to
Sort By:
Pageof 17
Cancers|June 21, 2020
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical DiscoveriesDanilo Fiore, Luca Vincenzo Cappelli, Paul Zumbo, et al.Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.Blood Advances|February 9, 2021
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular featuresXiaolong Alan Zhou, Jingyi Yang, Kimberly G Ringbloom, et al.Blood|June 22, 2016
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutationsAbner Louissaint, Kristian T Schafernak, Julia T Geyer, et al.Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.Leukemia|February 28, 2018
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignanciesMatthew L Cooper, Jaebok Choi, Karl Staser, et al.Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasDelphine C M Rolland, Venkatesha Basrur, Yoon-Kyung Jeon, et al.Blood Cancer Discovery|March 5, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.Pageof 17